BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14

• Press Releases

  New England Biolab® launches Monarch® Mag Cell-free RNA (cfRNA) Extraction Kit to enable total cfRNA isolation from biofluids

  August 4, 2026

   · 

  3 min read
• Press Releases

  Aqua Medical Names Bob Haggerty CEO to Take on Type 2 Diabetes

  August 4, 2026

   · 

  5 min read
• Press Releases

  NIPRO Launches Expanded Hemodialysis with ELISIO™-HX to U.S. Providers Following FDA Clearance

  August 4, 2026

   · 

  3 min read
• 

  Earnings

  Merck’s $10.8B Prometheus deal delivers another win—plus a Phase 2b miss

  The anti-TL1A antibody from Merck’s 2023 Prometheus buy delivered positive mid-stage results in a skin condition but failed in a certain type of lung disease, the Big Pharma revealed alongside second-quarter earnings.

  August 4, 2026

   · 

  3 min read

   · 

  Gabrielle Masson
• Press Releases

  Theralase(R) Engages Global One Media to Expand Global Investor Awareness

  August 4, 2026

   · 

  1 min read
• Press Releases

  Moderna Announces Initiation of Phase 1 Clinical Trial of mRNA-1469, Moderna’s Investigational Vaccine Against Bundibugyo Ebolavirus

  August 4, 2026

   · 

  5 min read
• Press Releases

  Health Canada authorizes vaccine clinical trial for Ebola disease caused by the Bundibugyo virus

  August 4, 2026

   · 

  2 min read
• Press Releases

  FUJIFILM Biotechnologies Transitions Leadership to Drive Next Phase of Operational Excellence

  August 4, 2026

   · 

  5 min read
• Press Releases

  TempraMed Announces Strategic Partnership with Stealth Health, a Leading Telemedicine Platform for Longevity and Wellness

  August 4, 2026

   · 

  1 min read
• Press Releases

  Defence Therapeutics Appoints Dr. Amie Phinney as President and Chief Executive Officer

  August 4, 2026

   · 

  1 min read